100 related articles for article (PubMed ID: 7992197)
1. Pharmacologically induced cessation of burst activity in nigral dopamine neurons: significance for the terminal dopamine efflux.
Nissbrandt H; Elverfors A; Engberg G
Synapse; 1994 Aug; 17(4):217-24. PubMed ID: 7992197
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of dopamine re-uptake: significance for nigral dopamine neuron activity.
Engberg G; Elverfors A; Jonason J; Nissbrandt H
Synapse; 1997 Feb; 25(2):215-26. PubMed ID: 9021902
[TBL] [Abstract][Full Text] [Related]
3. gamma-Hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB-receptors.
Engberg G; Nissbrandt H
Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):491-7. PubMed ID: 8114948
[TBL] [Abstract][Full Text] [Related]
4. Pallidal control of substantia nigra dopaminergic neuron firing pattern and its relation to extracellular neostriatal dopamine levels.
Lee CR; Abercrombie ED; Tepper JM
Neuroscience; 2004; 129(2):481-9. PubMed ID: 15501605
[TBL] [Abstract][Full Text] [Related]
5. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity.
Smith ID; Grace AA
Synapse; 1992 Dec; 12(4):287-303. PubMed ID: 1465742
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of firing rate and changes in the firing pattern of nigral dopamine neurons by gamma-hydroxybutyric acid (GHBA) are specifically induced by activation of GABA(B) receptors.
Erhardt S; Andersson B; Nissbrandt H; Engberg G
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):611-9. PubMed ID: 9686936
[TBL] [Abstract][Full Text] [Related]
7. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
[TBL] [Abstract][Full Text] [Related]
8. Effects of electrical stimulation of the central nucleus of the amygdala on the in vivo electrophysiological activity of rat nigral dopaminergic neurons.
Rouillard C; Freeman AS
Synapse; 1995 Dec; 21(4):348-56. PubMed ID: 8869165
[TBL] [Abstract][Full Text] [Related]
9. GABAB-receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra.
Engberg G; Kling-Petersen T; Nissbrandt H
Synapse; 1993 Nov; 15(3):229-38. PubMed ID: 8278899
[TBL] [Abstract][Full Text] [Related]
10. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Ashby CR; Minabe Y; Stemp G; Hagan JJ; Middlemiss DN
J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873
[TBL] [Abstract][Full Text] [Related]
11. Effects of scopolamine on dopamine neurons in the substantia nigra: role of the pedunculopontine tegmental nucleus.
Di Giovanni G; Shi WX
Synapse; 2009 Aug; 63(8):673-80. PubMed ID: 19360852
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cytochrome P450 2E1 induces an increase in extracellular dopamine in rat substantia nigra: a new metabolic pathway?
Nissbrandt H; Bergquist F; Jonason J; Engberg G
Synapse; 2001 Jun; 40(4):294-301. PubMed ID: 11309845
[TBL] [Abstract][Full Text] [Related]
13. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Nakamura K; Suzuki K; McCreary AC; Ashby CR
Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399
[TBL] [Abstract][Full Text] [Related]
14. Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex.
Linnér L; Endersz H; Ohman D; Bengtsson F; Schalling M; Svensson TH
J Pharmacol Exp Ther; 2001 May; 297(2):540-6. PubMed ID: 11303041
[TBL] [Abstract][Full Text] [Related]
15. Modulation of dopamine release by striatal 5-HT2C receptors.
Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
[TBL] [Abstract][Full Text] [Related]
16. Effect of the acute and chronic administration of the putative atypical antipsychotic drug Y-931 (8-fluoro-12- (4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3b][1,5] benzodiazepine maleate) on spontaneously active rat midbrain dopamine neurons: an in vivo electrophysiological study.
Minabe Y; Hashimoto K; Shirayama Y; Ashby CR
Synapse; 2004 Jan; 51(1):19-26. PubMed ID: 14579422
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR
Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat.
Fà M; Mereu G; Ghiglieri V; Meloni A; Salis P; Gessa GL
Synapse; 2003 Apr; 48(1):1-9. PubMed ID: 12557266
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of pyrethroid insecticides on extracellular dopamine in the striatum of freely moving rats.
Mubarak Hossain M; Suzuki T; Sato N; Sato I; Takewaki T; Suzuki K; Tachikawa E; Kobayashi H
Toxicol Appl Pharmacol; 2006 Nov; 217(1):25-34. PubMed ID: 16956637
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons.
Keath JR; Iacoviello MP; Barrett LE; Mansvelder HD; McGehee DS
J Neurophysiol; 2007 Dec; 98(6):3388-96. PubMed ID: 17942622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
